Who Paid My Doc
Nn8640-4263
Research payments
$2,214,931
Through program year 2025, $2,214,931 in research payments was reported against Nn8640-4263, across 6,604 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $62,490 | 33 |
| 2024 | Research | $255,991 | 358 |
| 2023 | Research | $241,784 | 1,569 |
| 2022 | Research | $320,071 | 689 |
| 2021 | Research | $354,884 | 1,173 |
| 2020 | Research | $531,677 | 2,036 |
| 2019 | Research | $448,034 | 746 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mary Abuzzahab Saint Paul, MN Named on 1,008 payments
- Quentin Vanmeter Atlanta, GA Named on 259 payments
- Aristides Maniatis Centennial, CO Named on 237 payments
- Eva Tsalikian Iowa City, IA Named on 228 payments
- Michael Stalvey Birmingham, AL Named on 221 payments
- Oscar Escobar Pittsburgh, PA Named on 206 payments
- John Fuqua Indianapolis, IN Named on 198 payments
- Lawrence Silverman Morristown, NJ Named on 179 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.